USANA HEALTH SCIENCES INC Quarterly Cash and Cash Equivalents, at Carrying Value in USD from Q4 2009 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Usana Health Sciences Inc quarterly Cash and Cash Equivalents, at Carrying Value history and growth rate from Q4 2009 to Q3 2024.
  • Usana Health Sciences Inc Cash and Cash Equivalents, at Carrying Value for the quarter ending September 28, 2024 was $365M, a 18.8% increase year-over-year.
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $365M +$57.8M +18.8% Sep 28, 2024 10-Q 2024-11-05
Q2 2024 $332M +$32.2M +10.7% Jun 29, 2024 10-Q 2024-08-06
Q1 2024 $328M +$32.9M +11.1% Mar 30, 2024 10-Q 2024-05-07
Q4 2023 $330M +$42M +14.6% Dec 30, 2023 10-Q 2024-11-05
Q3 2023 $307M +$60.2M +24.4% Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $300M +$69.8M +30.3% Jul 1, 2023 10-Q 2024-08-06
Q1 2023 $295M +$57.7M +24.3% Apr 1, 2023 10-Q 2024-05-07
Q4 2022 $288M +$48.6M +20.3% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $247M -$1.82M -0.73% Oct 1, 2022 10-Q 2023-11-07
Q2 2022 $230M -$35M -13.2% Jul 2, 2022 10-Q 2023-08-08
Q1 2022 $238M -$19.2M -7.48% Apr 2, 2022 10-Q 2023-05-09
Q4 2021 $240M -$72.1M -23.1% Jan 1, 2022 10-K 2024-02-27
Q3 2021 $249M -$29.7M -10.7% Oct 2, 2021 10-Q 2022-11-08
Q2 2021 $265M +$38M +16.7% Jul 3, 2021 10-Q 2022-08-09
Q1 2021 $257M +$62.9M +32.4% Apr 3, 2021 10-Q 2022-05-11
Q4 2020 $312M +$77.1M +32.8% Jan 2, 2021 10-K 2023-02-28
Q3 2020 $278M +$95.7M +52.4% Sep 26, 2020 10-Q 2021-11-10
Q2 2020 $227M -$3.99M -1.72% Jun 27, 2020 10-Q 2021-08-11
Q1 2020 $194M -$30.9M -13.8% Mar 28, 2020 10-Q 2021-05-11
Q4 2019 $235M +$20.5M +9.57% Dec 28, 2019 10-K 2022-03-01
Q3 2019 $183M -$57M -23.8% Sep 28, 2019 10-Q 2020-11-03
Q2 2019 $231M -$25M -9.74% Jun 29, 2019 10-Q 2020-08-04
Q1 2019 $225M -$41.2M -15.5% Mar 30, 2019 10-Q 2020-05-05
Q4 2018 $214M -$32.8M -13.3% Dec 29, 2018 10-K 2021-03-02
Q3 2018 $240M +$48M +25% Sep 29, 2018 10-Q 2019-11-05
Q2 2018 $256M +$27M +11.8% Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $266M +$89.9M +51% Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $247M +$71.4M +40.6% Dec 30, 2017 10-K 2020-02-25
Q3 2017 $192M +$57.2M +42.5% Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $229M +$117M +104% Jul 1, 2017 10-Q 2018-08-08
Q1 2017 $176M +$25.8M +17.2% Apr 1, 2017 10-Q 2018-05-09
Q4 2016 $176M +$32.6M +22.7% Dec 31, 2016 10-K 2019-02-26
Q3 2016 $135M -$39.7M -22.8% Oct 1, 2016 10-Q 2017-11-08
Q2 2016 $112M -$38.5M -25.5% Jul 2, 2016 10-Q 2017-08-09
Q1 2016 $151M +$21.9M +17.1% Apr 2, 2016 10-Q 2017-05-10
Q4 2015 $143M +$32.1M +28.9% Jan 2, 2016 10-K 2018-02-28
Q3 2015 $174M +$86.5M +98.5% Oct 3, 2015 10-Q 2016-11-09
Q2 2015 $151M +$32.7M +27.6% Jul 4, 2015 10-Q 2016-08-09
Q1 2015 $129M -$14.2M -9.92% Apr 4, 2015 10-Q 2016-05-11
Q4 2014 $111M -$26.2M -19.1% Jan 3, 2015 10-K 2018-02-28
Q3 2014 $87.7M -$27.6M -23.9% Sep 27, 2014 10-Q 2015-11-12
Q2 2014 $118M +$22.2M +23.1% Jun 28, 2014 10-Q 2015-08-12
Q1 2014 $143M +$71.7M +101% Mar 29, 2014 10-Q 2015-05-13
Q4 2013 $137M +$66.5M +93.9% Dec 28, 2013 10-K 2017-03-01
Q3 2013 $115M +$38.7M +50.6% Sep 28, 2013 10-Q 2014-11-06
Q2 2013 $96.1M +$30.5M +46.6% Jun 29, 2013 10-Q 2014-08-05
Q1 2013 $71M -$117K -0.16% Mar 30, 2013 10-Q 2014-05-07
Q4 2012 $70.8M +$20.5M +40.7% Dec 29, 2012 10-K 2016-03-01
Q3 2012 $76.6M +$40.3M +111% Sep 29, 2012 10-Q 2013-11-07
Q2 2012 $65.5M +$40.6M +163% Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $71.2M +$38.4M +118% Mar 31, 2012 10-Q 2013-05-07
Q4 2011 $50.4M $0 0% Dec 31, 2011 10-K 2014-03-13
Q3 2011 $36.3M +$13.4M +58.4% Oct 1, 2011 10-Q 2012-11-07
Q2 2011 $24.9M -$3.48M -12.3% Jul 2, 2011 10-Q 2012-08-08
Q1 2011 $32.7M Apr 2, 2011 10-Q 2012-05-10
Q4 2010 $50.4M +$36.7M +269% Jan 1, 2011 10-K 2015-03-17
Q3 2010 $22.9M Oct 2, 2010 10-Q 2011-11-09
Q2 2010 $28.4M Jul 3, 2010 10-Q 2011-08-10
Q4 2009 $13.7M Jan 2, 2010 10-K 2013-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.